Home » Topics » Regulatory

Regulatory
RSS

Lyrica indications broadened in E.U. to include central neuropathic pain

Sep. 19, 2006

Glivec approved in E.U. for additional cancer indications

Sep. 19, 2006

FDA approves first antifungal agent for prevention of IFIs caused by Aspergillus

Sep. 19, 2006

German approval for Foster in asthma

Aug. 31, 2006

Keppra receives FDA approval for juvenile myoclonic epilepsy

Aug. 24, 2006

CE Mark for Repel-CV to reduce adhesions following cardiac surgery

Aug. 24, 2006

Mexico first to approve Januvia

Aug. 9, 2006

ATryn approved for use in E.U.

Aug. 3, 2006

Xolegel approved for seborrheic dermatitis

July 31, 2006

Famvir approved for recurrent genital herpes and cold sores

July 31, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...